At $54-bn value, interest in GSK’s arm may lead to biggest-ever buyout
GlaxoSmithKline’s (GSK’s) consumer unit is drawing interest from private equity firms in what could lead to the biggest
Read more
Buyout
Trending Space
Keep Trending